Showing results (1091-1100 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|January 19, 2024
M6A methylation of FKFB3 reduced pyroptosis of gastric cancer by NLRP3Wanyuan Chen, Xiaolin Ye, Yun Chen, et al.
Anti-Cancer Drugs|March 25, 2024
Early dose reduction of osimertinib in advanced EGFR -mutated non-small cell lung cancerMarion Ferreira, Matthew I Ebia, Karen L Reckamp
Anti-Cancer Drugs|March 25, 2024
Tislelizumab plus chemotherapy is an optimal option for second-line treatment for advanced gastroesophageal junction adenocarcinomaPing Yang, Tao Pan, Ming-Kun Wang, et al.
Anti-Cancer Drugs|March 21, 2024
Furmonertinib and intrathecal pemetrexed chemotherapy rechallenges osimertinib-refractory leptomeningeal metastasis in a non-small cell lung cancer patient harboring EGFR20 R776S, C797S, and EGFR21 L858R compound EGFR mutations: a case reportGuoxia Jia, Shoaib Bashir, Minting Ye, et al.
Anti-Cancer Drugs|February 22, 2024
Neoadjuvant savolitinib targeted therapy for stage IIIB-N3 lung adenocarcinoma harboring mesenchymal-epithelial transition exon 14 skipping mutation: a case report and literature reviewLei Chen, Jin-Feng Chen, Jin-Tao He, et al.
Anti-Cancer Drugs|November 20, 2023
circ_0006528 promotes nonsmall cell lung cancer progression by sponging miR-892a and regulating NRAS expressionWeixi Guo, Hongming Liu, Ming Zhong, et al.
Anti-Cancer Drugs|November 10, 2023
Mechanism of gemcitabine combined with lobaplatin in interventional treatment of locally advanced cervical cancerYang Lin, Qiaoli Yang
Anti-Cancer Drugs|October 12, 2023
Molecular mechanisms of HCG18 in the sorafenib resistance of hepatocellular carcinomaHeping Li, Jie Hu, Lijie Qiu, et al.
Anti-Cancer Drugs|July 19, 2023
The effects of statin therapy on brain tumors, particularly glioma: a reviewAmjad Z Alrosan, Ghaith B Heilat, Zeinab Y Al Subeh, et al.
Anti-Cancer Drugs|August 14, 2023
Promising response of dabrafenib, trametinib, and osimertinib combination therapy for concomitant BRAF and EGFR-TKI resistance mutationsClint Taonaishe Chimbangu, Zhou Ya, Li Xi, et al.
Pageof 464